Login

Semizarov, Dimitri

Genomics in Drug Discovery and Development

Semizarov, Dimitri - Genomics in Drug Discovery and Development, ebook

123,40€

Ebook, PDF with Adobe DRM
ISBN: 9780470409763
DRM Restrictions

Printing134 pages with an additional page accrued every 6 hours, capped at 134 pages
Copy to clipboard22 excerpts

Early characterization of toxicity and efficacy would significantly impact the overall productivity of pharmaceutical R&D and reduce drug candidate attrition and failure. By describing the available platforms and weighing their relative advantages and disadvantages, including microarray data analysis, Genomics in Drug Discovery and Development introduces readers to the biomarker, pharmacogenomic, and toxicogenomics toolbox. The authors provide a valuable resource for pharmaceutical discovery scientists, preclinical drug safety department personnel, regulatory personnel, discovery toxicologists, and safety scientists, drug development professionals, and pharmaceutical scientists.

Keywords: drug efficacy, pharmaceutical R&D, pharmaceuticals, preclinical drug safety, personal medicine, genetic therapy, genomics, proteomics, microarray data analysis, toxicogenomics

Author(s)
 
Publisher
John Wiley and Sons, Inc.
Publication year
2009
Language
en
Edition
1
Page amount
448 pages
Category
Medicine, Health Care, Mode
Format
Ebook
eISBN (PDF)
9780470409763
Printed ISBN
9780470096048

Similar titles